PHARM RES-DORDR 润色咨询

PHARMACEUTICAL RESEARCH

出版年份:1984 年文章数:5840 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=474640, encodeId=37244e46400b, content=谁说比较容易,Pharmaceutical Research虽然分值不高,拒稿率却很高,并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 29 01:43:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472638, encodeId=3b884e2638b0, content=比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Nov 22 17:05:00 CST 2010, time=2010-11-22, status=1, ipAttribution=)]
    2011-03-29 匿名用户

    谁说比较容易,Pharmaceutical Research虽然分值不高,拒稿率却很高,并不容易投

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=474640, encodeId=37244e46400b, content=谁说比较容易,Pharmaceutical Research虽然分值不高,拒稿率却很高,并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Mar 29 01:43:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472638, encodeId=3b884e2638b0, content=比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Nov 22 17:05:00 CST 2010, time=2010-11-22, status=1, ipAttribution=)]
    2010-11-22 匿名用户

    比较容易

    0

共26条页码: 3/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分